Clinical trials are in need of a digital makeover
Healthcare companies are lagging behind. Oftentimes, clinical trial research still uses old-school processes like physical protocol binders, paper diaries, and decade old-software. Furthermore, only 5% of the U.S. population participates in clinical research. Andrea Coravos (MBA ’17) believes the time is ripe for innovative technologies – from virtual trials and digital biomarkers to improved software tools – to improve clinical trial execution and encourage broader participation from the public.